Big Pharma's Guy in the DEA Exposed, Steps Down | Thursday, 07/20/2023

The DEA's second-in-command steps down after his past consulting for big pharma companies (which have been the face of the opioid crisis) come to light, and whistleblowers inside the agency prepare to testify to congress that the administration's fentanyl strategy makes no sense - well, maybe it does, given these ties. Plus, would-be teachers in New York get paid millions for failing their credentialing tests that eighth graders could pass. And finally, Norfolk Southern Railway ignores the residents of East Palestine, Ohio to tout their ESG and DEI measures instead.Guests:Marguerite Connelly | Author, "Addicted to the Addicted: A Mother's Tale of Going from Heartbreak to Hopeful"Riley Lewis | Producer, Tipping Point with Kara McKinney & OAN PodcasterWilliam Wolfe | Former Senior Official, Trump AdministrationSteve Milloy | Biostatistician & Founder, junkscience.com